Ivor Cavill, PhD | Authors

Role of Iron in Optimizing Responses of Anemic Cancer Patients to Erythropoietin

April 01, 1999

Approximately 50% of cancer patients develop anemia. In the past, the only available treatment option for these patients was transfusion. Since the late 1980s, recombinant human erythropoietin (rHuEPO, epoetin alfa